565 related articles for article (PubMed ID: 28459614)
1. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.
Lehrnbecher T; Robinson P; Fisher B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; Castagnola E; Davis BL; Dupuis LL; Gaur AH; Tissing WJE; Zaoutis T; Phillips R; Sung L
J Clin Oncol; 2017 Jun; 35(18):2082-2094. PubMed ID: 28459614
[TBL] [Abstract][Full Text] [Related]
2. Guideline for the Management of Fever and Neutropenia in Pediatric Patients With Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update.
Lehrnbecher T; Robinson PD; Ammann RA; Fisher B; Patel P; Phillips R; Beauchemin MP; Carlesse F; Castagnola E; Davis BL; Elgarten CW; Groll AH; Haeusler GM; Koenig C; Santolaya ME; Tissing WJE; Wolf J; Alexander S; Hu H; Dupuis LL; Sung L
J Clin Oncol; 2023 Mar; 41(9):1774-1785. PubMed ID: 36689694
[TBL] [Abstract][Full Text] [Related]
3. Strategies for Empiric Management of Pediatric Fever and Neutropenia in Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: A Systematic Review of Randomized Trials.
Robinson PD; Lehrnbecher T; Phillips R; Dupuis LL; Sung L
J Clin Oncol; 2016 Jun; 34(17):2054-60. PubMed ID: 27022114
[TBL] [Abstract][Full Text] [Related]
4. Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation.
Lehrnbecher T; Phillips R; Alexander S; Alvaro F; Carlesse F; Fisher B; Hakim H; Santolaya M; Castagnola E; Davis BL; Dupuis LL; Gibson F; Groll AH; Gaur A; Gupta A; Kebudi R; Petrilli S; Steinbach WJ; Villarroel M; Zaoutis T; Sung L;
J Clin Oncol; 2012 Dec; 30(35):4427-38. PubMed ID: 22987086
[TBL] [Abstract][Full Text] [Related]
5. Clinical Practice Guideline for Systemic Antifungal Prophylaxis in Pediatric Patients With Cancer and Hematopoietic Stem-Cell Transplantation Recipients.
Lehrnbecher T; Fisher BT; Phillips B; Beauchemin M; Carlesse F; Castagnola E; Duong N; Dupuis LL; Fioravantti V; Groll AH; Haeusler GM; Roilides E; Science M; Steinbach WJ; Tissing W; Warris A; Patel P; Robinson PD; Sung L
J Clin Oncol; 2020 Sep; 38(27):3205-3216. PubMed ID: 32459599
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial.
Santolaya ME; Alvarez AM; Acuña M; Avilés CL; Salgado C; Tordecilla J; Varas M; Venegas M; Villarroel M; Zubieta M; Farfán M; de la Maza V; Vergara A; Valenzuela R; Torres JP
J Antimicrob Chemother; 2018 Oct; 73(10):2860-2866. PubMed ID: 30010931
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Invasive Fungal Risk Score in Cancer and Hematopoietic Stem Cell Transplantation Patients With Febrile Neutropenia.
Alali M; Giurcanu M; Elmuti L; Kumar M
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e334-e342. PubMed ID: 34224520
[TBL] [Abstract][Full Text] [Related]
8. Systematic review on efficacy and safety of empirical versus pre-emptive antifungal therapy among children with febrile neutropenia reveals paucity of data.
Sachdeva M; Malik M; Pradhan P; Kaur K; Dogra S; Mathew JL
Mycoses; 2024 Apr; 67(4):e13722. PubMed ID: 38606896
[TBL] [Abstract][Full Text] [Related]
9. Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients.
Science M; Robinson PD; MacDonald T; Rassekh SR; Dupuis LL; Sung L
Pediatr Blood Cancer; 2014 Mar; 61(3):393-400. PubMed ID: 24424789
[TBL] [Abstract][Full Text] [Related]
10. Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation.
Lehrnbecher T; Fisher BT; Phillips B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Castagnola E; Davis BL; Dupuis LL; Egan G; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; van de Wetering M; Wolf J; Cabral S; Robinson PD; Sung L
Clin Infect Dis; 2020 Jun; 71(1):226-236. PubMed ID: 31676904
[TBL] [Abstract][Full Text] [Related]
11. 2016 guideline strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan.
Ko BS; Chen WT; Kung HC; Wu UI; Tang JL; Yao M; Chen YC; Tien HF; Chang SC; Chuang YC; Lin DT; ; ; ; ; ;
J Microbiol Immunol Infect; 2018 Jun; 51(3):287-301. PubMed ID: 28781151
[TBL] [Abstract][Full Text] [Related]
12. Adherence to practice guidelines for the management of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation: An observational study in a referral center in Iran.
Ekhtiari Kolour SR; Shahrami B; Kargar M; Taghvaye Masoumi H; Amini S; Vaezi M; Hadjibabaie M; Mohammadi M; Sadeghi K
J Oncol Pharm Pract; 2023 Jul; 29(5):1112-1118. PubMed ID: 35392730
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
14. Febrile Neutropenia Syndromes in Children: Risk Factors and Outcomes of Primary, Prolonged, and Recurrent Fever.
Alali M; David MZ; Ham SA; Danziger-Isakov L; Pisano J
J Pediatr Hematol Oncol; 2021 Oct; 43(7):e962-e971. PubMed ID: 34133386
[TBL] [Abstract][Full Text] [Related]
15. Risk Adapted Management of Febrile Neutrepenia and Early Cessation of Empirical Antibiotherapy in Hematopoietic Stem Cell Transplantation Setting.
Kaya AH; Tekgündüz E; Duygu F; Koca D; Bekdemir F; Batgi H; Ulu Uncu B; Yiğenoğlu TN; Dal MS; Çakar Kızıl M; Altuntaş F
Balkan Med J; 2017 Apr; 34(2):132-139. PubMed ID: 28418340
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and management burden of invasive fungal infections after autologous hematopoietic stem cell transplantation: 10-year experience at a European Pediatric Cancer Center.
Linke C; Tragiannidis A; Ahlmann M; Fröhlich B; Wältermann M; Burkhardt B; Rossig C; Groll AH
Mycoses; 2019 Oct; 62(10):954-960. PubMed ID: 31332851
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.
Fisher BT; Robinson PD; Lehrnbecher T; Steinbach WJ; Zaoutis TE; Phillips B; Sung L
J Pediatric Infect Dis Soc; 2018 Aug; 7(3):191-198. PubMed ID: 28549148
[TBL] [Abstract][Full Text] [Related]
18. The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantation.
Lehrnbecher T
Expert Rev Anti Infect Ther; 2019 Jul; 17(7):489-499. PubMed ID: 31149864
[No Abstract] [Full Text] [Related]
19. Association Between Depth of Neutropenia and Clinical Outcomes in Febrile Pediatric Cancer and/or Patients Undergoing Hematopoietic Stem-cell Transplantation.
Alali M; David MZ; Danziger-Isakov LA; Bartlett AH; Petty LA; Schwartz T; Pisano J
Pediatr Infect Dis J; 2020 Jul; 39(7):628-633. PubMed ID: 32176187
[TBL] [Abstract][Full Text] [Related]
20. Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders.
Qiu KY; Liao XY; Fang JP; Xu HG; Li Y; Huang K; Zhou DH
Transpl Infect Dis; 2019 Jun; 21(3):e13066. PubMed ID: 30859662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
